Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Immunochem Therapeutics LLC has 1 pending office action in Biotechnology & Pharmaceuticals. The proceeding involves 1 examiner and 1 art unit, leaving the examination assignment narrowly defined.
AGGARWAL, SAHIL CHANDER is the busiest examiner, with 1 pending matter. Counsel can direct analysis toward the action’s biotechnology claims and the examiner’s stated requirements.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AGGARWAL, SAHIL CHANDER | 1 | 66.7% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18840375 | TREATMENT OF INTRACRANIAL HEMORRHAGE | AGGARWAL, SAHIL CHANDER | 1623 | §102§103§112DPOther | Non-Final OA | — | Pending | Aug 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialImmunochem Therapeutics LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sahil Chander Aggarwal has the most, with 1 of Immunochem Therapeutics LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
